EDITORIAL
Published on 23 May 2023
Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy
doi 10.3389/fimmu.2023.1218845
- 575 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunomodulatory Factors, Conversion, and Postoperative Adjuvant Therapy for Hepatobiliary Tumors Based on Immunotherapy
Immunomodulatory Factors, Conversion, and Postoperative Adjuvant Therapy for Hepatobiliary Tumors Based on Immunotherapy
6,032
Total Downloads
17k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 26 Apr 2023
Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review
doi 10.3389/fimmu.2023.1073531
- 2,869 views
- 4 citations
REVIEW
Published on 20 Jan 2023
Radiation therapy in the era of immune treatment for hepatocellular carcinoma
doi 10.3389/fimmu.2023.1100079
- 3,320 views
- 10 citations
REVIEW
Published on 02 Sep 2022
Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy
doi 10.3389/fimmu.2022.992611
- 3,755 views
- 12 citations
ORIGINAL RESEARCH
Published on 17 Aug 2022
A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
doi 10.3389/fimmu.2022.997316
- 2,835 views
- 3 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 17kTopic views
- 10kArticle views
- 6,032Article downloads